Roche Receives CE Mark for Mass Spectrometry Antibiotics Monitoring
The approval expands the company's automated mass spectrometry menu to 39 tests.
The approval expands the company's automated mass spectrometry menu to 39 tests.
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
Roche has received CE mark approval for its cobas Mass Spec solution, marking a milestone in its global launch of mass spectrometry testing.
This collaboration aims to advance a smartphone-based hemoglobin test for accessible diagnostics of anemia and other health conditions.
The Tox Explorer Collection consists of a comprehensive library of analytes, allowing for faster identification and targeted screening assays with 1,500 compounds confirmed in a single analysis.